Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...

A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.

Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...

Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease ...

“Obviously, there was an element of shock. I didn’t feel any pain. There were no other symptoms besides the lump," said ...

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...

No longer confined to cancer centers, skin complications of cancer therapies are now commonly encountered at the community level and require the care of a dermatologist.

Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision.